NCT05372861 is a clinical trial in Endophthalmitis, sponsored by Medical University of Graz.

Who is sponsoring NCT05372861?

NCT05372861 is sponsored by Medical University of Graz.

What condition does NCT05372861 study?

NCT05372861 studies Endophthalmitis.

Is NCT05372861 still recruiting?

NCT05372861 is currently recruiting now. Last updated 30 September 2025.

Last reviewed 2025-09-30 · How we verify

NCT05372861

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nanopore Sequencing in Ophthalmology

Recruiting now Last updated 30 September 2025

What this trial tests

trial in Endophthalmitis in 20 participants. Currently enrolling.

Timeline

22 April 2022

Primary endpoint
1 December 2026

1 December 2027

Quick facts

Lead sponsor	Medical University of Graz
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	20
Start date	22 April 2022
Primary completion	1 December 2026
Estimated completion	1 December 2027
Sites	1 location across Austria

Conditions studied

Endophthalmitis — all drugs for Endophthalmitis →

Sponsor

Medical University of Graz

Who can join

Adults 18 to 99, any sex, with Endophthalmitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this pilot study, the feasibility of the Oxford Nanopore MinION to identify pathogens from vitrectomy samples in eyes with endophthalmitis shall be assessed. The MinION is a low cost commercially available device for DNA/ RNA analysis that, in studies, has been used for pathogen determination in various infectious diseases as well as for the genetic characterization of hematologic tumors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endophthalmitis

Currently open trials in the same condition.

NCT07176130 — Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore · active not recruiting

Other Medical University of Graz trials

Trials by the same sponsor.

NCT07498244 — Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients · recruiting
NCT07492823 — Clinical Applicability of Liquid Biopsy in Chondrosarcoma · not yet recruiting
NCT07297615 — 3D Liver Volumetry · NA · not yet recruiting
NCT07588282 — The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intention · NA · recruiting
NCT07376096 — Liquid Biopsy in Germ Cell Tumors · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05372861 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Graz
Last refreshed: 30 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05372861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing